« Back
Home /
Recombinant Influenza Hemagglutinin (H7 Anhui)

Recombinant Influenza Hemagglutinin (H7 Anhui)

Item no.	IBT-1502-001
Manufacturer	Integrated BioTherapeutics
Amount	50 ug
Category	Peptides & Proteins Recombinant Proteins Western Blot ELISA Cardiovascular Research Heart Failure Myocardial Infarction Hypertension
Type	Proteins Recombinant
Applications	WB, ELISA
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Influenza rHA H7 Anhui
Available
Manufacturer - Type	protein
Manufacturer - Category	Influenza
Manufacturer - Targets	Influenza Hemagglutinin Glycoprotein from virus strain A/Anhui/1/2013 (H7N9)
Expression	SF9 cells
Purification	Column chromatography
Notable Features	Agglutination
Description	Recombinant, Influenza Hemagglutinin Full-Length Glycoprotein (rHA GP) from virus strain A/Anhui/1/2013 (H7N9) supplied as an affinity purified protein, produced in Sf9 insect cells using baculovirus for expression, purified by FPLC
Pathogen Strain	Influenza
Lineage	A/Anhui/1/2013 (H7N9)
Target Pathogen	Influenza A

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

IBT-1502-001-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 24 days

Compare

Add to wishlist

Get an offer